Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Abedin SE"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hamid O; The Angeles Clinic and Research Institute, a Cedars-Sinai Affiliate, Los Angeles, California, USA ohamid@theangelesclinic.org mark.middleton@oncology.ox.ac.uk., Hassel JC; University Hospital Heidelberg, Heidelberg, Germany., Shoushtari AN; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Weill Cornell Medical College, New York, New York, USA., Meier F; Skin Cancer Center at the National Center for Tumor Diseases and University Cancer Centre, Dresden, Germany.; Department of Dermatology, University Hospital Carl Gustav Carus, Dresden, Germany., Bauer TM; Tennessee Oncology, Nashville, Tennessee, USA., Salama AKS; Duke University, Durham, North Carolina, USA., Kirkwood JM; University of Pittsburgh Medical Center Cancer Center, Pittsburgh, Pennsylvania, USA., Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Lorigan PC; The Christie NHS Foundation Trust, Manchester, UK., Mauch C; University Hospital Cologne, Cologne, Germany., Orloff M; Sidney Kimmel Cancer Center, Jefferson University, Philadelphia, Pennsylvania, USA., Evans TRJ; Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK., Holland C; Immunocore LLC, Rockville, Maryland, USA., Edukulla R; Immunocore LLC, Rockville, Maryland, USA., Abedin SE; Immunocore LLC, Rockville, Maryland, USA., Middleton MR; Department of Oncology, Medical Sciences Division, University of Oxford, Oxford, UK ohamid@theangelesclinic.org mark.middleton@oncology.ox.ac.uk.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Jun; Vol. 11 (6).